Issue 3/2010

Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays (191 — 197)

J. BI, A. L. GUO, Y. R. LAI, B. LI, J. M. ZHONG, H. Q. WU, Z. XIE, Y. L. HE, Z. L. LV, S. H. LAU, Q. WANG, X. H. HUANG, L. J. ZHANG, J. M. WEN, X. Y. GUAN

DOI: 10.4149/neo_2010_03_191

Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer (198 — 206)

D. NARITA, A. ANGHEL, A. M. CIMPEAN, D. IZVERNARIU, N. CIREAP, R. ILINA, S. URSONIU

DOI: 10.4149/neo_2010_03_198

In vitro and in vivo effects of reovirus on HPV16-transformed mice cells (207 — 214)

K. FIGOVA, E. SOBOTKOVA, M. DUSKOVA, V. LUDVIKOVA, V. VONKA, T. ECKSCHLAGER

DOI: 10.4149/neo_2010_03_207

Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia (215 — 221)

J. BREZINOVA, A. BERKOVA, S. VCELIKOVA, Z. ZEMANOVA, S. IZAKOVA, I. SAROVA, H. CECHOVA, J. TAJTLOVA, L. GROSOVA, L. LIZCOVA, E. MALINOVA, M. ZEMANOVA, E. CMUNT, J. KARBAN, M. TRNENY, J. SCHWARZ, K. MICHALOVA

DOI: 10.4149/neo_2010_03_215

Nuclear translocation of telomerase reverse transcriptase: a critical process in chemical induced hepatocellular carcinogenesis (222 — 227)

Y. CHEN, Q. KONG

DOI: 10.4149/neo_2010_03_222

Transcriptional inactivation of secreted frizzled-related protein 1 by promoter hypermethylation as a potential biomarker for non-small cell lung cancer (228 — 233)

Y. W. ZHANG, Y. F. MIAO, J. YI, J. GENG, R. WANG, L. B. CHEN

DOI: 10.4149/neo_2010_03_228

Increased 18F-FDG uptake and expression of Glut1 in the EMT transformed breast cancer cells induced by TGF-β (234 — 240)

W. LI, Z. WEI, Y. LIU, H. LI, R. REN, Y. TANG

DOI: 10.4149/neo_2010_03_234

Prognostic stratification using F-18 FDG PET/CT in patients with advanced stage (Stage III and IV) non-small cell lung cancer (241 — 246)

Y. S. KIM, M. K. LEE, S. J. KIM, I. J. KIM, Y. K. KIM, W. S. JO, S. K. PARK

DOI: 10.4149/neo_2010_03_241

High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers (247 — 252)

B. YU, H. YANG, C. ZHANG, Q. WU, Y. SHAO, J. ZHANG, M. GUAN, J. WAN, W. ZHANG

DOI: 10.4149/neo_2010_03_247

Annexin A1 expression and its prognostic significance in human breast cancer (253 — 259)

L. P. WANG, J. BI, C. YAO, X. D. XU, X. X. LI, S. M. WANG, Z. L. LI, D. Y. ZHANG, M. WANG, G. Q. CHANG

DOI: 10.4149/neo_2010_03_253

Is there any venous gradient in serum thyroglobulin levels in patients with differentiated thyroid cancer? (260 — 263)

K. GULBEN, U. BERBEROGLU, A. ULUOCAK

DOI: 10.4149/neo_2010_03_260

MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients (264 — 269)

O. SLABY, R. LAKOMY, P. FADRUS, R. HRSTKA, L. KREN, E. LZICAROVA, M. SMRCKA, M. SVOBODA, H. DOLEZALOVA, J. NOVAKOVA, D. VALIK, R. VYZULA, J. MICHALEK

DOI: 10.4149/neo_2010_03_264

Treatment of newly diagnosed patients with acute promyelocytic leukemia with modified spanish treatment protocol (270 — 279)

I. ORAVCOVA, B. CZAKO, E. DEMECKOVA, L. DEMITROVICOVA, R. GREKSAK, P. KOTOUCEK, M. MEGO, E. MIKUSKOVA, K. RICHTEROVA, F. AL_SABTI, M. MISTRIK

DOI: 10.4149/neo_2010_03_270

Population-based study of BRCA1/2 mutations: Family history based criteria identify minority of mutation carriers (280 — 285)

M. MATEJU, J. STRIBRNA, M. ZIKAN, Z. KLEIBL, M. JANATOVA, S. KORMUNDA, J. NOVOTNY, P. SOUCEK, L. PETRUZELKA, P. POHLREICH

DOI: 10.4149/neo_2010_03_280